Fate Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +41.1% | +401.8% | -7.9% | +32.7% | +39.9% | +10.8% | +102.3% | +41.9% | +105.9% | +48.0% | -23.4% | -28.3% | -12.9% | -27.6% | |
| – | +46.4% | +458.1% | -8.7% | +31.6% | +42.1% | +9.9% | +100.0% | +10.7% | +117.7% | +28.1% | -20.7% | -34.0% | -12.0% | -28.5% | |
| – | +42.3% | +494.7% | -9.1% | +32.0% | +36.7% | +0.4% | +114.2% | -47.6% | +67.7% | -20.2% | -54.1% | -31.7% | -13.9% | +29.3% | |
| – | +42.3% | +494.7% | -9.1% | +32.0% | +42.1% | +9.6% | +99.1% | +10.2% | +118.1% | +27.5% | -29.2% | -27.7% | -11.5% | -27.0% | |
| – | – | – | – | – | – | – | – | +167.6% | +312.2% | +57.3% | +343.5% | -95.3% | +93.8% | -74.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +11.4% | -30.2% | +48.1% | +80.0% | -26.9% | +61.5% | +101.0% | +122.8% | +182.9% | +402.2% | +8.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +9.2% | -92.6% | +382.9% | +30.9% | -26.8% | +28.4% | +87.0% | +9.4% | +313.8% | +1.9% | -8.7% | -37.8% | -11.5% | -8.4% | |
| – | +32.0% | -5.2% | -0.4% | +193.4% | +13.0% | -27.2% | +146.7% | +2.0% | +207.7% | -5.0% | +40.3% | -65.7% | -1.5% | -6.4% | |
| – | +55.5% | -10.8% | -10.7% | +323.9% | +24.9% | -11.4% | -66.4% | -30.6% | +98.3% | +66.2% | +0.9% | +9.7% | +20.1% | -38.5% | |
| – | -34.1% | -44.5% | -5.4% | +54.4% | -6.2% | +79.7% | +150.6% | +38.5% | +7.9% | +37.1% | -4.0% | -42.9% | +98.5% | -71.6% | |
| – | -51.8% | -100.0% | – | -40.9% | -76.6% | +492.1% | -16.0% | – | – | – | – | – | – | – | |
| – | – | – | -44.3% | +34.2% | +92.3% | +5.5% | +107.9% | +52.5% | +57.1% | +76.6% | -28.7% | -23.9% | -13.5% | -35.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +122.8% | +3.5% | +24.6% | +24.6% | +32.2% | +33.9% | +21.3% | +20.8% | +15.0% | +2.2% | +1.6% | +15.5% | +4.5% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.